VDAC1 and cervical carcinoma: We also evaluated the correlations of VDAC1 expression with the prognosis of patients with cervical cancer, and found that cervical cancer patients with positive VDAC1 immunoreactivity had a higher probability of recurrence (p=0.0025) and lower overall survival (p=0.0036) as compared to those with negative VDAC1 (Figure 2B & C).